All patients (n = 64) | PTV ≤ 110 ml (n = 32) | PTV > 110 ml (n = 32) | |
---|---|---|---|
Headache (≤ II° CTC) | 7/64 (10.9%) | 2/32 (6.3%) | 5/32 (15.6%) |
Nausea/vomiting (≤ II° CTC) | 4/64 (6.3%) | 3/32 (9.3%) | 1/32 (3.1%) |
Seizures (≤ II° CTC) | 5/64 (7.8%) | 2/32 (6.2%) | 3/32 (9.3%) |
Skin reaction (≤ II° CTC) | 7/64 (10.9%) | 3/32 (9.3%) | 4/32 (12.5%) |
Mucosa reaction (≤ II° CTC) | 2/64 (3.1%) | 1/32 (3.1%) | 1/32 (3.1%) |
Ear toxicity (≤ II° CTC) | 0/64 (0%) | 0/64 (0%) | 0/64 (0%) |
Infections (≤ II° CTC) | 3/64 (4.6%) | 1/32 (3.1%) | 2/32 (6.3%) |